Meeting
2020 ASCO Virtual Scientific Program
A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers.
Authors
Kambiz Rahbar
University Hospital Münster, Münster, Germany
Kambiz Rahbar , Mark S. Kidd , Ignat A. Drozdov , Alexandra Kitz , Anna Malczewska , Pawel Rajwa , Martin Boegemann , Christof Bernemann , Lisa Bodei , Irvin Mark Modlin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5574)
DOI
10.1200/JCO.2020.38.15_suppl.5574
Abstract #
5574
Poster Bd #
155
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluation of a novel transcriptomic tumor signature (PROSTest) as response biomarker for 177Lu-PSMA therapy in advanced prostate cancer.
First Author: Alin Chirindel
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection.
First Author: Irvin Mark Modlin
Poster
2023 ASCO Genitourinary Cancers Symposium
Prediction of early prostate cancer recurrence using a liquid biopsy approach.
First Author: Kambiz Rahbar
Poster
2020 Genitourinary Cancers Symposium
Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer.
First Author: Vittorio Fasulo